| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000039871 |
| Receipt No. | R000045467 |
| Scientific Title | Efficacy and safety evaluation of ACTH therapy for developmental and epileptic encephalopathy |
| Date of disclosure of the study information | 2020/05/01 |
| Last modified on | 2021/09/18 (Ver. 4) |
| Basic information | ||
| Public title | Is ACTH therapy effective for developmental and epileptic encephalopathy? | |
| Acronym | ACTH therapy for DEE | |
| Scientific Title | Efficacy and safety evaluation of ACTH therapy for developmental and epileptic encephalopathy | |
| Scientific Title:Acronym | ACTH therapy for DEE | |
| Region |
|
|
| Condition | ||
| Condition | Developmental and Epileptic Encephalopathy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate Safety and efficacy of ACTH therapy |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Safety of ACTH therapy |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients who have been treated at department of pediatrics, Hokkaido University Hospital from April, 2003.
2. Patients who have diagnosed as infantile spasms at Hokkaido University Hospital 3. Patients who have treated by ACTH therapy |
|||
| Key exclusion criteria | 1. Patients who have been evaluated as inappropriate candidate by principle investigator | |||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hokkaido University Hospital | ||||||
| Division name | Department of Pediatrics | ||||||
| Zip code | 060-8648 | ||||||
| Address | North 14, West 5, Kita-ku, Sapporo | ||||||
| TEL | 011-716-1161 | ||||||
| siraisi@med.hokudai.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hokkaido University Hospital | ||||||
| Division name | Department of Pediatrics | ||||||
| Zip code | 060-8648 | ||||||
| Address | North 14, West 5, Kita-ku, Sapporo | ||||||
| TEL | 011-716-1161 | ||||||
| Homepage URL | |||||||
| yu_ueda@med.hokudai.ac.jp | |||||||
| Sponsor | |
| Institute | Hokkaido University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hokkaido University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hokkaido University Clinical Research Review |
| Address | North 14, West 5, Kita-ku, Sapporo |
| Tel | 011-716-1161 |
| crjimu@huhp.hokudai.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045467 |